Literature DB >> 28945013

Pro-Regenerative Hydrogel Restores Scarless Skin during Cutaneous Wound Healing.

Guoming Sun1.   

Abstract

The transformation of fibrotic healing process to regenerative one has great potential to fully restore wounded skin. The M2 macrophage phenotype promotes constructive tissue remodeling and instructs tissue repair in a regenerative manner. It is hypothesized that hydrogels that can establish robustness of endogenous cells to regulate M2 phenotype will promote constructive dermal remodeling. Toward this end, a series of dextran-based bioabsorbable hydrogels are developed and self-crosslinkable dextran-isocyanatoethyl methacrylate-ethylamine (DexIEME) is identified as the potential scaffold. The initial screening study revealed that DexIEME has superior biocompatibility in varying concentrations. Although DexIEME brings about low proinflammatory responses, it promotes M2 macrophage phenotype. Then the optimized hydrogel formulation is tested for acute skin injuries using both murine and porcine models. Preliminary data demonstrated that the innovative DexIEME hydrogel promotes complete skin regeneration with hair regrowth on pre-existing scars, while untreated scars remain intact. Preclinical studies further demonstrated that the DexIEME hydrogel regenerated perfect skin during deep porcine wound healing. Overall, the approach to investigate immune-modulated hydrogels yields pro-regenerative DexIEME hydrogel, which may lead to greater clinical success in treating deep dermal injury and attenuating scar formation.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  dextran; hydrogel; regeneration; scarless; wound

Mesh:

Substances:

Year:  2017        PMID: 28945013     DOI: 10.1002/adhm.201700659

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  10 in total

Review 1.  Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review.

Authors:  Martyna Zagórska-Dziok; Marcin Sobczak
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

Review 2.  Engineering immune-responsive biomaterials for skin regeneration.

Authors:  Pingli Wu; Yangyang Liang; Guoming Sun
Journal:  Biomater Transl       Date:  2021-03-28

3.  ADM Scaffolds Generate a Pro-regenerative Microenvironment During Full-Thickness Cutaneous Wound Healing Through M2 Macrophage Polarization via Lamtor1.

Authors:  Chengmin He; Zhi Yang; Ying Jin; Xiaoyang Qi; Jin Chu; Xiaoyuan Deng
Journal:  Front Physiol       Date:  2018-06-04       Impact factor: 4.566

Review 4.  Regeneration of Dermis: Scarring and Cells Involved.

Authors:  Alexandra L Rippa; Ekaterina P Kalabusheva; Ekaterina A Vorotelyak
Journal:  Cells       Date:  2019-06-18       Impact factor: 6.600

Review 5.  Skin Tissue Substitutes and Biomaterial Risk Assessment and Testing.

Authors:  Houman Savoji; Brent Godau; Mohsen Sheikh Hassani; Mohsen Akbari
Journal:  Front Bioeng Biotechnol       Date:  2018-07-26

Review 6.  Biomimetic Hydrogels to Promote Wound Healing.

Authors:  Fei Fan; Sanjoy Saha; Donny Hanjaya-Putra
Journal:  Front Bioeng Biotechnol       Date:  2021-09-20

7.  Spatiotemporally dynamic therapy with shape-adaptive drug-gel for the improvement of tissue regeneration with ordered structure.

Authors:  Ya-Nan Fu; Yongsan Li; Bo Deng; Yingjie Yu; Fang Liu; Lei Wang; Guang Chen; Lei Tao; Yen Wei; Xing Wang
Journal:  Bioact Mater       Date:  2021-06-23

Review 8.  Recent Advances in Bioengineered Scaffolds for Cutaneous Wound Healing.

Authors:  Jianghui Qin; Fang Chen; Pingli Wu; Guoming Sun
Journal:  Front Bioeng Biotechnol       Date:  2022-03-01

9.  Sequential gastrodin release PU/n-HA composite scaffolds reprogram macrophages for improved osteogenesis and angiogenesis.

Authors:  Limei Li; Qing Li; Li Gui; Yi Deng; Lu Wang; Jianlin Jiao; Yingrui Hu; Xiaoqian Lan; Jianhong Hou; Yao Li; Di Lu
Journal:  Bioact Mater       Date:  2022-04-01

Review 10.  P311, Friend, or Foe of Tissue Fibrosis?

Authors:  Leslie Stradiot; Inge Mannaerts; Leo A van Grunsven
Journal:  Front Pharmacol       Date:  2018-10-12       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.